- Home
- CHEK vs HSCS Comparison
CHEK vs HSCS Comparison
Compare CHEK & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- HSCS
- Stock Information
- Founded
- CHEK 2004
- HSCS 2007
- Country
- CHEK Israel
- HSCS United States
- Employees
- CHEK N/A
- HSCS N/A
- Industry
- CHEK Medical Electronics
- HSCS Medical Specialities
- Sector
- CHEK Health Care
- HSCS Health Care
- Exchange
- CHEK Nasdaq
- HSCS Nasdaq
- Market Cap
- CHEK 4.0M
- HSCS 3.7M
- IPO Year
- CHEK 2015
- HSCS 2022
- Fundamental
- Price
- CHEK $0.67
- HSCS $3.23
- Analyst Decision
- CHEK
- HSCS Strong Buy
- Analyst Count
- CHEK 0
- HSCS 2
- Target Price
- CHEK N/A
- HSCS $13.00
- AVG Volume (30 Days)
- CHEK 22.2K
- HSCS 10.2K
- Earning Date
- CHEK 05-14-2025
- HSCS 03-13-2025
- Dividend Yield
- CHEK N/A
- HSCS N/A
- EPS Growth
- CHEK N/A
- HSCS N/A
- EPS
- CHEK N/A
- HSCS N/A
- Revenue
- CHEK N/A
- HSCS N/A
- Revenue This Year
- CHEK N/A
- HSCS N/A
- Revenue Next Year
- CHEK N/A
- HSCS N/A
- P/E Ratio
- CHEK N/A
- HSCS N/A
- Revenue Growth
- CHEK N/A
- HSCS 261.17
- 52 Week Low
- CHEK $0.56
- HSCS $2.36
- 52 Week High
- CHEK $3.04
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- CHEK 41.37
- HSCS 52.20
- Support Level
- CHEK $0.64
- HSCS $2.97
- Resistance Level
- CHEK $0.71
- HSCS $3.36
- Average True Range (ATR)
- CHEK 0.06
- HSCS 0.35
- MACD
- CHEK 0.00
- HSCS 0.03
- Stochastic Oscillator
- CHEK 31.06
- HSCS 50.41
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.